Optichronix
WebOptiChroniX was built using partnerships and research from the leading international medical institutions. Learn more CHRONIC CARE DELIVERED Through decades of … About OptiChroniX ; Founders; Team; Scientific Advisors; Contact; meet our … Learn everything from health and wellness tips to research studies on healthy aging … Welcome to a new generation of Digital Health Coaches providing a Cognitive … Get in contact with OptiChroniX, the Cognitive Care Solution Company that … Profiles of the Scientific Advisory Board of OptiChroniX. Lutz is Professor of … OptiChroniX es una innovadora compañía de salud digital con sede en Houston, … OptiChroniX aspires to develop myAVOS aligned with one or more of UN’s global … Personalise and democratise early dementia care. Proactively identify early … Nearly two-thirds of these suggestions target vascular risk factors and lifestyle, … WebApr 13, 2024 · OptiChroniX myAvos Le Dam app app development app launch health tech News fresh funds Serial Entrepreneurship c-suite switchup Building Houston Serial …
Optichronix
Did you know?
WebRene Gilvert is the COO and Founder at OptiChroniX. OptiChroniX COO and Founder Jun 1, 2024. Related Hubs. Edit Related Hubs Section. Hub Name . CB Rank (Hub) Therapeutics Startups . 20,739: Medical Device Seed Stage Companies With Fewer Than 1000 Employees . 19,973: mHealth Startups . 35,643:
Webwww.cordadschultehuis.nl WebFeb 21, 2024 · OptiChroniX.com - Health Coach, Better Treatment Philippe Krolicki Philippe has more than 20 years of experience leading both strategic and operational cross-functional teams. Philippe Krolicki ... Feb 23, 2024. optichronix.com . Philippe Krolicki is Director of Worldwide Commercial Development at Pfizer Inc. Within this role, Mr. Krolicki …
WebOptiChroniX is a Swiss Digital Therapeutics company dedicated to improving brain health early. We strive to optimize lifestyle and make medicine smart, so as to improve clinical outcomes, quality of life, cost-effectiveness and budget impact of clinical treatment. Read More Contact Who is OptiChroniX Headquarters WebOptiChroniX is a digital therapeutics platform focused on self-directed brain care, and our other venture is the creator of Mila Nova, who is intended to become the world's first AI-driven...
WebApr 13, 2024 · OptiChroniX myAvos Le Dam app app development app launch health tech News fresh funds Serial Entrepreneurship c-suite switchup Building Houston Serial Entrepreneurship onboarding biz Houston energy tech accelerator names 3 startups, announces first out-of-state pitch day Natalie Harms Apr 13, 2024, 11:02 am
WebWow, so much excitement and #innovation at the Renal Physicians Association this last week in #NewOrleans with #valuebasedhealthcare driving new models of care… high speed trains in the united statesWebMar 15, 2024 · OptiChroniX has raised a total of $419.2K in funding over 6 rounds. Their latest funding was raised on Mar 15, 2024 from a Pre-Seed round. OptiChroniX is funded by 3 investors. EIT Health and InnoSuisse are the most recent investors. high speed trains in south africaWebJan 13, 2024 · 1 INTRODUCTION. As many as 40% of dementia cases can be attributed to modifiable risk factors. 1 Much of that risk reduction can be accomplished by changing … high speed trains in americaWebOptiChroniX is an American-Swiss Digital Health company dedicated to improve Brain Health for Millions. We support a healthy brain by providing a late life dementia risk predictor, continuous... high speed trains in spain mapWebNews. Hikma launches Icosapent Ethyl Capsules, 0.5g, in the US. Watch Said Darwazah, Executive Chairman and Chief Executive Officer discuss our 2024 financial results. how many days since 09/08/2020WebOptiChroniX is a Swiss Digital Therapeutics company dedicated to improving brain health early. We strive to optimize lifestyle and make medicine smart, so as to improve clinical … high speed trains investmentWebDownload apps by OptiChroniX, including myAVOS. iPad & iPhone. myAVOS how many days since 09/06/2022